Extendicare Announces 2017 Third Quarter Results
Nov 09, 2017 22:00 pm UTC| Business
MARKHAM, Ontario, Nov. 09, 2017 -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:EXE) today reported results for the three and nine months ended September 30, 2017. Results are presented in Canadian dollars...
Winthrop Realty Liquidating Trust to Make Distribution of $0.90 Per Beneficial Unit
Nov 09, 2017 22:00 pm UTC| Business
BOSTON, Nov. 09, 2017 -- Winthrop Realty Liquidating Trust (the "Trust") announced today the Trust's trustees have approved a liquidating distribution of $0.90 per common beneficial unit in the Trust payable in cash on...
Nuance Named CES 2018 Innovation Awards Honoree
Nov 09, 2017 22:00 pm UTC| Business
BURLINGTON, Mass., Nov. 09, 2017 -- Nuance Communications, Inc. (NASDAQ:NUAN) today announced that it has been named a CES 2018 Innovation Awards Honoree for its Dragon Drive connected car platform in the award...
AMD Ryzen™ Threadripper™ 1950X Wins CES 2018 Best of Innovation Award
Nov 09, 2017 22:00 pm UTC| Business
SUNNYVALE, Calif., Nov. 09, 2017 -- Today, AMD (NASDAQ:AMD) announced that its high-performance, enthusiast Ryzen™ Threadripper™ 1950X processor is the CES 2018 Best of Innovation Award winner in the Computer Hardware...
Nov 09, 2017 21:59 pm UTC| Business
NORTHVALE, N.J., Nov. 09, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, announced results...
Nov 09, 2017 21:59 pm UTC| Business
NEW YORK, Nov. 09, 2017 -- Wolf Haldenstein Adler Freeman Herz LLP announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts against Genocea...
Seabridge Gold Files Third Quarter Report to Shareholders and its Financial Statements and MD&A
Nov 09, 2017 21:55 pm UTC| Business
TORONTO, Nov. 09, 2017 -- Seabridge Gold (TSX:SEA) (NYSE:SA) reported today that it has filed its Report to Shareholders, Financial Statements and Management’s Discussion and Analysis for the three and nine months ended...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update